RIF-1, a novel nuclear receptor corepressor that associates with the nuclear matrix

Journal of Cellular Biochemistry

Volumn 102, Issue 4, 2007, Pages 1021-1035

  Li, Hui Joyce ^a   Haque, Zaffar K ^a   Chen, Amy ^a,b   Mendelsohn, Michael ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Corepressor; Nuclear matrix protein; Nuclear receptor; Transcription

Indexed keywords

CELL NUCLEUS RECEPTOR; PROTEIN; PROTEIN RIF 1; REPRESSOR PROTEIN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; BINDING SITES; CLONING, MOLECULAR; HUMANS; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR MATRIX; NUCLEAR PROTEINS; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 35648993041     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21340     Document Type: Article

References (56)

1. Alland L, Muhle R, Hou H, Jr., Potes J, Chin L, Schreiber-Agus N, DePinho RA. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression [see comments]. Nature 387:49-55.
2. Baek SH, Rosenfeld MG. 2004. Nuclear receptor coregulators: Their modification codes and regulatory mechanism by translocation. Biochem Biophys Res Commun 319:707-714.
3. Barrett TJ, Spelsberg TC. 1999. Nuclear matrix and steroid hormone action. Vitam Horm 55:127-163.
4. Bode J, Benham C, Knopp A, Mielke C. 2000. Transcriptional augmentation: Modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements). Crit Rev Eukaryot Gene Expr 10:73-90.
5. Cavaillès V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG. 1995. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751.
6. Chen JD, Evans RM. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors [see comments]. Nature 377:454-457.
7. Chen JD, Umesono K, Evans RM. 1996. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci USA 93:7567-7571.
8. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR. 1998. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 12:3343-3356.
9. Debril MB, Dubuquoy L, Feige JN, Wahli W, Desvergne B, Auwerx J, Gelman L. 2005. Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity. J Mol Endocrinol 35:503-517.
10. DeFranco DB, Guerrero J. 2000. Nuclear matrix targeting of steroid receptors: Specific signal sequences and acceptor proteins. Crit Rev Eukaryot Gene Expr 10:39-44.
11. Delage-Mourroux R, Martini PG, Choi I, Kraichely DM, Hoeksema J, Katzenellenbogen BS. 2000. Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. J Biol Chem 275:35848-35856.
12. Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee WH, Elledge SJ. 1993. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev 7:555-569.
13. Feng W, Ribeiro RC, Wagner RL, Nguyen H, Apriletti JW, Fletterick RJ, Baxter JD, Kushner PJ, West BL. 1998. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280:1747-1749.
14. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS. 2003. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574.
15. Georgescu SP, Li JH, Lu Q, Karas RH, Brown M, Mendelsohn ME. 2005. Modulator recognition factor 1, an AT-rich interaction domain family member, is a novel corepressor for estrogen receptor alpha. Mol Endocrinol 19:2491-2501.
16. Hager GL, Nagaich AK, Johnson TA, Walker DA, John S. 2004. Dynamics of nuclear receptor movement and transcription. Biochim Biophys Acta 1677:46-51.
17. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression [see comments]. Nature 387:43-48.
18. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor [see comments]. Nature 377:397-404.
19. Ismail A, Nawaz Z. 2005. Nuclear hormone receptor degradation and gene transcription: An update. IUBMB Life 57:483-490.
20. Ivanova M, Dobrzycka KM, Jiang S, Michaelis K, Meyer R, Kang K, Adkins B, Barski OA, Zubairy S, Divisova J, Lee AV, Oesterreich S. 2005. Scaffold attachment factor B1 functions in development, growth, and reproduction. Mol Cell Biol 25:2995-3006.
21. Jiang S, Meyer R, Kang K, Osborne CK, Wong J, Oesterreich S. 2006. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor. Mol Endocrinol 20:311-320.
22. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
23. Kawai-Kowase K, Owens GK. 2007. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am J Physiol Cell Physiol 292: C59-C69.
24. Li C, Wu RC, Amazit L, Tsai SY, Tsai MJ, O'Malley BW. 2006. Specific amino acid residues in the bHLH domain of SRC-3 are essential for its nuclear localization and proteasome-dependant turnover. Mol Cell Biol 27:1296-1308.
25. Li H, Chen JD. 1998. The receptor-associated coactivator 3 activates transcription through CREB-binding protein recruitment and autoregulation. J Biol Chem 273: 5948-5954.
26. Li H, Gomes PJ, Chen JD. 1997. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci USA 94:8479-8484.
27. Li H, Leo C, Zhu J, Wu X, O'Neil J, Park EJ, Chen JD. 2000. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol 20:1784-1796.
28. Lonard DM, O'Malley BW. 2006. The expanding cosmos of nuclear receptor coactivators. Cell 125:411-414.
29. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. 1995. The nuclear receptor superfamily: The second decade. Cell 83:835-839.
30. Martini PG, Delage-Mourroux R, Kraichely DM, Katzenellenbogen BS. 2000. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol Cell Biol 20:6224-6232.
31. Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, Stein GS. 1995. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: Interactions with the osteocalcin gene promoter. Biochemistry 34:13125-13132.
32. Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P, Katzenellenbogen BS. 1999. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc Natl Acad Sci USA 96:6947-6952.
33. Muratani M, Tansey WP. 2003. How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 4:192-201.
34. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380.
35. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator- activated receptor-gamma. Nature 395:137-143.
36. Oesterreich S. 2003. Scaffold attachment factors SAFB1 and SAF B2: Innocent bystanders or critical players in breast tumorigenesis? J Cell Biochem 90:653-661.
37. Oesterreich S, Zhang Q, Hopp T, Fuqua SA, Michaelis M, Zhao HH, Davie JR, Osborne CK, Lee AV. 2000. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation. Mol Endocrinol 14:369-381.
38. Park EJ, Schroen DJ, Yang M, Li H, Li L, Chen JD. 1999. SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor. Proc Natl Acad Sci USA 96:3519-3524.
39. Privalsky ML. 2004. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315-360.
40. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
41. Shao W, Keeton EK, McDonnell DP, Brown M. 2004. Coactivator AIB1 links estrogen receptor transcriptional activity and stability. Proc Natl Acad Sci USA 101:11599-11604.
42. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL. 1998. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937.
43. Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A, Watson PH, Murphy LC. 2000. Expresssion of a repressor of estrogen receptor activity in human breast tumors: Relationship to some known prognostic markers. Cancer Res 60:2796-2799.
44. Stein GS, Montecino M, van Wijnen AJ, Stein JL, Lian JB. 2000. Nuclear structure-gene expression interrelationships: Implications for aberrant gene expression in cancer. Cancer Res 60:2067-2076.
45. Townson SM, Dobrzycka KM, Lee AV, Air M, Deng W, Kang K, Jiang S, Kioka N, Michaelis K, Oesterreich S. 2003. SAFB2, a new scaffold attachment factor homolog and estrogen receptor corepressor. J Biol Chem 278:20059-20068.
46. Townson SM, Kang K, Lee AV, Oesterreich S. 2004. Structure-function analysis of the estrogen receptor alpha corepressor scaffold attachment factor- B1: Identification of a potent transcriptional repression domain. J Biol Chem 279:26074-26081.
47. Treuter E, Albrektsen T, Johansson L, Leers J, Gustafsson JA. 1998. A regulatory role for RIP140 in nuclear receptor activation. Mol Endocrinol 12:864-881.
48. Umesono K, Murakami KK, Thompson CC, Evans RM. 1991. Direct repeats as selective response elements for the thyroid hormone induced gene expression through a common responsive element. Cell 65:1255-1266.
49. Wei LN, Farooqui M, Hu X. 2001. Ligand-dependent formation of retinoid receptors, receptor-interacting protein 140 (RIP140), and histone deacetylase complex is mediated by a novel receptor-interacting motif of R IP140. J Biol Chem 276:16107-16112.
50. Wei LN, Hu X, Chandra D, Seto E, Farooqui M. 2000. Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J Biol Chem 275:40782-40787.
51. Weston AD, Blumberg B, Underhill TM. 2003. Active repression by unliganded retinoid receptors in development: Less is sometimes more. J Cell Biol 161:223-228.
52. White R, Leonardsson G, Rosewell I, Ann Jacobs M, Milligan S, Parker M. 2000. The nuclear receptor corepressor nrip1 (RIP140) is essential for female fertility. Nat Med 6:1368-1374.
53. Windahl SH, Treuter E, Ford J, Zilliacus J, Gustafsson JA, McEwan IJ. 1999, The nuclear-receptor interacting protein (RIP) 140 binds to the human glucocorticoid receptor and modulates hormone-dependent transactivation. J Steroid Biochem Mol Biol 71:93-102.
54. Wu RC, Smith CL, O'Malley BW. 2005. Transcriptional regulation by steroid receptor coactivator phosphorylation. Endocr Rev 26:393-399.
55. Xu L, Glass CK, Rosenfeld MG. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 9:140-147.
56. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. 2004. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6:931-940.